Director Discretionary Decision: Refer | Jul 24, 2025 | PAPER | BOARD |
OPDIVO FDA Approval label and prescribing information, December 2014 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Commemorating the 15th Anniversary of the Biologics Price Competition and Innovation Act, FDA.gov | Jul 10, 2025 | EXHIBIT | PETITIONER |
Patent Term Extension certificate for U.S. Patent No. 8,008,449 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Notice of Final Determination Eligible for U.S. Patent No. 8,008,449 | Jul 10, 2025 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,358,289 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Bristol-Myers Squibb Company Form 10-K (Dec. 31, 2024) | Jul 10, 2025 | EXHIBIT | PETITIONER |
European Patent No. EP3464373 B1 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Decision Revoking EP3464373 B1, mailed April 19, 2023 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Notices of Opposition to European Patent No. EP3464373 B1 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Request for revocation of European Patent No. EP3464373 B1, mailed April 13, 2023 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Consolidated list of references cited in Oppositions of European Patent No. EP3464373 B1 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Biosimilar-Related IPR Petitions, Biologicshq.com | Jul 10, 2025 | EXHIBIT | PETITIONER |
Biosimilar-Related IPRs by Reference Product, Biologicshq.com | Jul 10, 2025 | EXHIBIT | PETITIONER |
Patents Subject to Biosimilar-Related IPRs and Litigations, Biologicshq.com | Jul 10, 2025 | EXHIBIT | PETITIONER |
Biosimilars Council White Paper, Breaking Through on Biosimilars, Delivering More-Affordable, Innovative Medicines to America's Patients | Jul 10, 2025 | EXHIBIT | PETITIONER |
Biosimilars in the United States 2023-2027, Iqvia.com | Jul 10, 2025 | EXHIBIT | PETITIONER |
Biosimilars Forum Applauds the Trump Administration for Drug Pricing Executive Order, Biosimilarsforum.org | Jul 10, 2025 | EXHIBIT | PETITIONER |
The U.S. Generic & Biosimilar Medicines Savings Report, September 2024 | Jul 10, 2025 | EXHIBIT | PETITIONER |
Petitioner's Opposition to Patent Owner's Discretionary Denial Brief | Jul 10, 2025 | PAPER | PETITIONER |
PATENT OWNER’S REQUEST FOR DISCRETIONARY DENIAL | Jun 10, 2025 | PAPER | PATENT OWNER |
U.S. Patent No. 9,856,320 | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Press Release, Bristol-Myers Squibb, FDA Approves Yervoy™ (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer (Mar. 25, 2011) | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Press Release, Bristol-Myers Squibb, Bristol-Myers Squibb Receives Accelerated Approval of Opdivo (nivolumab) from the U.S. Food and Drug Administration (Dec. 22, 2014) | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
YERVOY, FDA Approved label and prescribing information, Rev. 5/2025 | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
OPDIVO, FDA Approved label and prescribing information, Rev. 5/2025 | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Amgen Pipeline | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
NCT05907122, “A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma” (Last Update Posted Nov. 27, 2024) | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Press Release, Amgen, Amgen Reports First Quarter 2025 Financial Results (May 1, 2025) | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Press Release, Amgen, Amgen Reports Fourth Quarter and Full Year 2024 Financial Results (Feb. 4, 2025) | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Amgen Biosimilars | Jun 10, 2025 | EXHIBIT | PATENT OWNER |
Notice filing date accorded to petition | Apr 10, 2025 | PAPER | BOARD |
Notice: Mandatory Notice | Mar 21, 2025 | PAPER | PATENT OWNER |
Notice: Power of Attorney | Mar 21, 2025 | PAPER | PATENT OWNER |
U.S. Patent No. 11,332,529 ("'529 Patent") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 11,332,529 - Part 1 of 6 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 11,332,529 - Part 2 of 6 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 11,332,529 - Part 3 of 6 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 11,332,529 - Part 4 of 6 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 11,332,529 - Part 5 of 6 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 11,332,529 - Part 6 of 6 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Curriculum Vitae of Dr. Arta M. Monjazeb | Feb 28, 2025 | EXHIBIT | PETITIONER |
NCT02060188 Version 1, ClinicalTrials.gov ("NCT-188") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Zhang et al., World J Gastrointest Oncol. 2013 Feb 15; 5(2):12-9. ("Zhang") | Feb 28, 2025 | EXHIBIT | PETITIONER |
NCT01968109 Version 1, ClinicalTrials.gov ("NCT-109") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Le et al., N Engl J Med. 2015 Jun 25;372(26):2509-20. ("Le") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Hammers et al., J Clin Oncol., 33:15_suppl, May 20, 2015 ("Hammers") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Xiao et al., Cancer Discov. 2015 Jan; 5(1):16-8. ("Xiao") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Larkin et al., N Engl J Med. 2015 Jul 2; 373(1):23-34. ("Larkin") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Curran et al., Proc Natl Acad Sci USA. 2010 Mar 2;107(9):4275-80 (“Curran") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Wolchok et al., N Engl J Med. 2013 Jun 2; 369(2):122-33. | Feb 28, 2025 | EXHIBIT | PETITIONER |
Llosa et al., Cancer Discov. 2015 Jan; 5(1):43-51. ("Llosa") | Feb 28, 2025 | EXHIBIT | PETITIONER |
National Cancer Institute, Dictionary of Cancer Terms "Monotherapy" | Feb 28, 2025 | EXHIBIT | PETITIONER |
Declaration of Prescott Lassman | Feb 28, 2025 | EXHIBIT | PETITIONER |
Curriculum Vitae of Prescott Lassman | Feb 28, 2025 | EXHIBIT | PETITIONER |
ClinicalTrials.gov, Glossary of Common Site Terms | Feb 28, 2025 | EXHIBIT | PETITIONER |
Affidavit of Nathaniel E. Frank-White Re: EX1008 & EX1011 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Raedler et al., Am Health Drug Benefits. 2015 Mar; 8(Spec Feature):180-3. | Feb 28, 2025 | EXHIBIT | PETITIONER |
Lipson et al., Clin Cancer Res. 2011 Nov 15;17(22):6958-62. (“Lipson-2011”) | Feb 28, 2025 | EXHIBIT | PETITIONER |
Merriam-Webster Collegiate Dictionary, "Colorectal" | Feb 28, 2025 | EXHIBIT | PETITIONER |
National Cancer Institute, Dictionary of Cancer Terms, "overall survival" | Feb 28, 2025 | EXHIBIT | PETITIONER |
Pawlik et al., Dis Markers. 2004; 20(4-5):199-206 ("Pawlik") | Feb 28, 2025 | EXHIBIT | PETITIONER |
de'Angelis et al., Acta Biomed. 2018 Dec 17; 89(9-S):97-101. ("de'Angelis") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Lindor et al., J Clin Oncol. 2002 Feb 15; 20(4):1043-8. ("Lindor") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Boland et al., Cancer Res. 1998 Nov 15; 58(22):5248-57. ("Boland") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Smyrk et al., Cancer. 2001 Jun 15; 91(12):2417-22. ("Smyrk") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Mathijssen et al., Oncologist. 2007 Aug; 12(8):913-23. ("Mathijssen") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Wang et al., J Clin Pharmacol. 2009 Sep; 49(9):1012-24. ("Wang") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Postow et al., N Engl J Med. 2015 May 21; 372(21):2006-17. ("Postow") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Le et al., Supplementary Appendix 1. N Engl J Med. 2015 Jun 25; 372(26) | Feb 28, 2025 | EXHIBIT | PETITIONER |
van Eeghen et al., J Gastrointest Oncol. 2015 Dec; 6(6):605-12. | Feb 28, 2025 | EXHIBIT | PETITIONER |
Merriam-Webster Medical Dictionary, "monotherapy" | Feb 28, 2025 | EXHIBIT | PETITIONER |
Lipson et al., Clin Cancer Res. 2013 Jan 15;19(2):462-8. ("Lipson-2013") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Pernot et al., . World J Gastroenterol. 2014 Apr 14; 20(14):3738-50. | Feb 28, 2025 | EXHIBIT | PETITIONER |
de la Chapelle et al., J Clin Oncol. 2010 Jul 10; 28(20):3380–3387. | Feb 28, 2025 | EXHIBIT | PETITIONER |
Le et al., Protocol. N Engl J Med. 2015 Jun 25;372(26):2509-20. | Feb 28, 2025 | EXHIBIT | PETITIONER |
Feng et al., Br J Clin Pharmacol. 2014 Jan 17; 78(1):106-17. ("Feng") | Feb 28, 2025 | EXHIBIT | PETITIONER |
U.S. Patent Application Publication No. 2017/0158776 A1 | Feb 28, 2025 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,008,449 | Feb 28, 2025 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,900,587 | Feb 28, 2025 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,984,720 | Feb 28, 2025 | EXHIBIT | PETITIONER |
Kroemer et al., OncoImmunology. 2015 Jun 5; 4(7):e1058597. (“Kroemer”) | Feb 28, 2025 | EXHIBIT | PETITIONER |
Mansh, Yale J Biol Med. 2011 Dec; 84(4):381–389. ("Mansh") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Topalian et al., N Engl J Med. 2012 Jun 28; 366(26):2443-54. ("Topalian") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Brahmer et al., J Clin Oncology. 2010 Jul 1; 28(19):3167–3175. ("Brahmer") | Feb 28, 2025 | EXHIBIT | PETITIONER |
National Cancer Institute, "nivolumab" | Feb 28, 2025 | EXHIBIT | PETITIONER |
Antonia et al., J Clin Oncology. 2015 May 20; 33(15S) | Feb 28, 2025 | EXHIBIT | PETITIONER |
Duraiswamy et al., Cancer Res. 2013 Jun 15; 73(12):3591-603. ("Duraiswamy") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Callahan et al., J Leukoc Biol. 2013 Jul; 94(1): 41–53. ("Callahan") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Bai et al., Clin Pharmacokinet. 2012 Feb 1; 51(2):119-35. ("Bai") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Monjazeb et al., Clin Cancer Res. 2021 May 1; 27(9):2470–2480. ("Monjazeb") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Declaration of Sylvia D. Hall-Ellis, Ph.D. | Feb 28, 2025 | EXHIBIT | PETITIONER |
Affidavit of Nathaniel E. Frank-White (Internet Archive) | Feb 28, 2025 | EXHIBIT | PETITIONER |
ClinicalTrials.gov, Clinical Trial Reporting Requirements | Feb 28, 2025 | EXHIBIT | PETITIONER |
Press Release: National Institutes of Health Launches "ClinicalTrials.gov" | Feb 28, 2025 | EXHIBIT | PETITIONER |
Zarin et al., Chest. 2009 Jul; 136(1):295–303. | Feb 28, 2025 | EXHIBIT | PETITIONER |
ClinicalTrials.gov, How to Edit Your Study Record, | Feb 28, 2025 | EXHIBIT | PETITIONER |
National Center for Biotechnology Information, About ClinicalTrials.gov | Feb 28, 2025 | EXHIBIT | PETITIONER |
ClinicalTrials.gov, Trends and Charts on Registered Studies | Feb 28, 2025 | EXHIBIT | PETITIONER |
Barbee et al., Annals of Pharmacotherapy. 2015, 49(8):907–937. ("Barbee") | Feb 28, 2025 | EXHIBIT | PETITIONER |
Power of Attorney | Feb 28, 2025 | PAPER | PETITIONER |
Declaration of Dr. Arta M. Monjazeb | Feb 28, 2025 | EXHIBIT | PETITIONER |
Petition for Inter Partes Review | Feb 28, 2025 | PAPER | PETITIONER |